255 related articles for article (PubMed ID: 32376956)
1. Childhood vaccines and antibiotic use in low- and middle-income countries.
Lewnard JA; Lo NC; Arinaminpathy N; Frost I; Laxminarayan R
Nature; 2020 May; 581(7806):94-99. PubMed ID: 32376956
[TBL] [Abstract][Full Text] [Related]
2. Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study.
Lewnard JA; Rogawski McQuade ET; Platts-Mills JA; Kotloff KL; Laxminarayan R
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008520. PubMed ID: 32776938
[TBL] [Abstract][Full Text] [Related]
3. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
[TBL] [Abstract][Full Text] [Related]
5. Prevention of pneumococcal disease through vaccination.
Gentile A; Bazán V
Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
[TBL] [Abstract][Full Text] [Related]
6. Acute respiratory infections: the forgotten pandemic. Communiqué from the International Conference on Acute Respiratory Infections, held in Canberra, Australia, 7-10 July 1997.
Int J Tuberc Lung Dis; 1998 Jan; 2(1):2-4. PubMed ID: 9562104
[TBL] [Abstract][Full Text] [Related]
7. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
[TBL] [Abstract][Full Text] [Related]
8. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.
Dagan R; Sikuler-Cohen M; Zamir O; Janco J; Givon-Lavi N; Fraser D
Pediatr Infect Dis J; 2001 Oct; 20(10):951-8. PubMed ID: 11642629
[TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
[TBL] [Abstract][Full Text] [Related]
10. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
[TBL] [Abstract][Full Text] [Related]
11. Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.
Ustrup M; Madsen LB; Bygbjerg IC; Konradsen F
Dan Med Bull; 2011 Oct; 58(10):A4323. PubMed ID: 21975154
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
Madhi SA; Bamford L; Ngcobo N
S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal resistance in perspective: how well are we combating it?
Amsden GW
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S125-8. PubMed ID: 14770075
[TBL] [Abstract][Full Text] [Related]
14. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?
Steele AD; Victor JC; Carey ME; Tate JE; Atherly DE; Pecenka C; Diaz Z; Parashar UD; Kirkwood CD
Hum Vaccin Immunother; 2019; 15(6):1215-1227. PubMed ID: 30735087
[TBL] [Abstract][Full Text] [Related]
15. Performance of rotavirus vaccines in developed and developing countries.
Jiang V; Jiang B; Tate J; Parashar UD; Patel MM
Hum Vaccin; 2010 Jul; 6(7):532-42. PubMed ID: 20622508
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Nov; 11():CD008521. PubMed ID: 23152260
[TBL] [Abstract][Full Text] [Related]
17. An overview of rotavirus vaccination programs in developing countries.
Hallowell BD; Tate J; Parashar U
Expert Rev Vaccines; 2020 Jun; 19(6):529-537. PubMed ID: 32543239
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccines: targeting the developing world.
Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
Soares-Weiser K; Maclehose H; Bergman H; Ben-Aharon I; Nagpal S; Goldberg E; Pitan F; Cunliffe N
Cochrane Database Syst Rev; 2012 Feb; (2):CD008521. PubMed ID: 22336845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
